Literature DB >> 33657921

Imaging findings of cutaneous angiosarcoma of the scalp: Comparison with cutaneous squamous cell carcinoma.

Masaya Kawaguchi1, Hiroki Kato1, Natsuko Suzui2, Tatsuhiko Miyazaki2, Hiroyuki Tomita3, Akira Hara3, Kanako Matsuyama4, Mariko Seishima4, Masayuki Matsuo1.   

Abstract

PURPOSE: This study aimed to evaluate imaging findings of cutaneous angiosarcoma (cAS) of the scalp compared with those of cutaneous squamous cell carcinoma (cSCC).
METHODS: This study included 15 patients with primary cAS and 10 with primary cSCC of the scalp. Seven patients with cAS and eight with cSCC underwent magnetic resonance imaging, and 11 patients with cAS and eight with cSCC underwent 18F-fluorodeoxyglucose-positron emission tomography/computed tomography imaging. Imaging findings for both pathologies were retrospectively reviewed and compared.
RESULTS: All 15 cAS cases were elevated lesions with an obtuse angle, invading the subcutaneous fat tissue. Multiple lesions were observed in only five cAS cases (33%) and no cSCC cases. Maximum diameter-to-height ratio was significantly higher in cAS than in cSCC (3.3 ± 1.0 versus 2.3 ± 0.6; p < 0.01). On T2-weighted images, intratumoral hypointensity (86% versus 13%; p < 0.01) and mixed hyper- and hypointensity (71% versus 0%; p < 0.01) were observed more frequently in cAS than in cSCC. No significant differences were observed between cAS and cSCC regarding flow void (29% versus 25%; p = 0.656). Maximum standardized uptake values were marginally significantly lower in cAS than in cSCC (5.6 ± 3.1 versus 10.5 ± 6.6; p = 0.078).
CONCLUSIONS: Cases of cAS of the scalp always exhibited flat elevated lesions with invasion of the subcutaneous fat tissue. Compared with cSCC, intratumoral hypointensity and mixed hyper- and hypointensity on T2-weighted images were more frequent in cAS. These findings will help with the differential diagnosis of cAS.

Entities:  

Keywords:  18F-FDG-PET/CT; Cutaneous angiosarcoma; MRI; cutaneous squamous cell carcinoma; scalp

Mesh:

Substances:

Year:  2021        PMID: 33657921      PMCID: PMC8447824          DOI: 10.1177/1971400921998941

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  23 in total

1.  Angiosarcoma of the scalp and face: the Mayo Clinic experience.

Authors:  Samir H Patel; Richard E Hayden; Michael L Hinni; William W Wong; Robert L Foote; Shadi Milani; Qing Wu; Stephen J Ko; Michele Y Halyard
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-04       Impact factor: 6.223

Review 2.  Kaposi Sarcoma and Cutaneous Angiosarcoma: Guidelines for Diagnosis and Treatment.

Authors:  C Requena; M Alsina; D Morgado-Carrasco; J Cruz; O Sanmartín; C Serra-Guillén; B Llombart
Journal:  Actas Dermosifiliogr (Engl Ed)       Date:  2018-09-24

Review 3.  Angiosarcoma: clinical and imaging features from head to toe.

Authors:  Ayman H Gaballah; Corey T Jensen; Sarah Palmquist; Perry J Pickhardt; Alper Duran; Gregory Broering; Khaled M Elsayes
Journal:  Br J Radiol       Date:  2017-05-04       Impact factor: 3.039

4.  Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007.

Authors:  Jorge Albores-Saavedra; Arnold M Schwartz; Donald E Henson; Lara Kostun; Alexandra Hart; David Angeles-Albores; Fredy Chablé-Montero
Journal:  Ann Diagn Pathol       Date:  2010-12-28       Impact factor: 2.090

5.  A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.

Authors:  Matthew G Fury; Cristina R Antonescu; Kimberly J Van Zee; Murray F Brennan; Robert G Maki
Journal:  Cancer J       Date:  2005 May-Jun       Impact factor: 3.360

6.  Prognostic value of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cutaneous angiosarcoma: A retrospective study of 18 cases.

Authors:  Hiroshi Umemura; Osamu Yamasaki; Tatsuya Kaji; Toshihisa Hamada; Masaki Otsuka; Kenji Asagoe; Keiji Iwatsuki
Journal:  J Dermatol       Date:  2017-03-31       Impact factor: 4.005

7.  Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.

Authors:  Sonia Mahajan; Christopher A Barker; Bhuvanesh Singh; Neeta Pandit-Taskar
Journal:  Nucl Med Commun       Date:  2019-07       Impact factor: 1.690

Review 8.  CT and MRI features of scalp lesions.

Authors:  Masaya Kawaguchi; Hiroki Kato; Masayuki Matsuo
Journal:  Radiol Med       Date:  2019-07-03       Impact factor: 3.469

Review 9.  Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.

Authors:  Yasuhiro Fujisawa; Koji Yoshino; Taku Fujimura; Yoshiyuki Nakamura; Naoko Okiyama; Yosuke Ishitsuka; Rei Watanabe; Manabu Fujimoto
Journal:  Front Oncol       Date:  2018-03-02       Impact factor: 6.244

Review 10.  Cutaneous angiosarcoma: update on biology and latest treatment.

Authors:  Yoshihiro Ishida; Atsushi Otsuka; Kenji Kabashima
Journal:  Curr Opin Oncol       Date:  2018-03       Impact factor: 3.645

View more
  3 in total

1.  Prognostic value of 18F-FDG PET/CT and MRI features in patients with high-risk and very-high-risk cutaneous squamous cell carcinoma.

Authors:  Masaya Kawaguchi; Hiroki Kato; Kanako Matsuyama; Yoshifumi Noda; Fuminori Hyodo; Masayuki Matsuo
Journal:  Br J Radiol       Date:  2022-01-07       Impact factor: 3.629

Review 2.  Imaging findings of malignant skin tumors: radiological-pathological correlation.

Authors:  Masaya Kawaguchi; Hiroki Kato; Yoshifumi Noda; Kazuhiro Kobayashi; Tatsuhiko Miyazaki; Fuminori Hyodo; Masayuki Matsuo
Journal:  Insights Imaging       Date:  2022-03-22

3.  Imaging findings of trichilemmal cyst and proliferating trichilemmal tumour.

Authors:  Masaya Kawaguchi; Hiroki Kato; Natsuko Suzui; Tatsuhiko Miyazaki; Hiroyuki Tomita; Akira Hara; Kanako Matsuyama; Mariko Seishima; Masayuki Matsuo
Journal:  Neuroradiol J       Date:  2021-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.